Skip to main content
L

Limin Group Co., Ltd. — Investor Relations & Filings

Ticker · 002734 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,829 across all filing types
Latest filing 2026-04-16 Annual Report
Country CN China
Listing Shenzhen Stock Exchange 002734

About Limin Group Co., Ltd.

https://www.chinalimin.com

Limin Group Co., Ltd. specializes in the research, development, production, and sale of crop protection products, focusing primarily on fungicides, insecticides, and herbicides. The company maintains a diverse portfolio that includes active ingredients and formulations such as Mancozeb, Cymoxanil, Fosetyl-aluminum, and Glufosinate-ammonium. It operates large-scale manufacturing facilities and emphasizes technical innovation through dedicated research centers. Limin Group serves a global clientele, providing solutions aimed at improving agricultural productivity and food security. Its operations encompass the entire value chain from chemical synthesis to final product distribution, ensuring quality control and supply chain stability for international and domestic markets.

Recent filings

Filing Released Lang Actions
2025年年度报告摘要
Annual Report Classification · 1% confidence The document is explicitly titled '利民控股集团股份有限公司2025年年度报告摘要' (Limin Chemical Group Co., Ltd. 2025 Annual Report Summary). It contains key financial data, business summaries, and shareholder information, and explicitly states that it is a summary of the full annual report. According to the filing definitions, an annual report summary is a component of the 10-K category (Annual Report). FY 2025
2026-04-16 Chinese
公司关于提请股东会授权董事会办理以简易程序向特定对象发行股票的公告
Share Issue/Capital Change Classification · 1% confidence The document is an official corporate announcement by Limin Group Co., Ltd. concerning a proposed issuance of new A shares via a simplified procedure to specific target investors, detailing authorization scope, issuance size, pricing, lock-up periods, and use of proceeds. This fits the definition of a Share Issue/Capital Change announcement.
2026-04-16 Chinese
公司董事和高级管理人员薪酬管理制度
Remuneration Information Classification · 1% confidence The document is a detailed internal policy (“薪酬管理制度”) governing directors’ and senior management compensation—covering pay determination, performance bonuses, long-term incentives, adjustment and clawback rules. This fits the “Remuneration Information” category (DEF 14A) which covers reports detailing executive and director compensation structures and policies.
2026-04-16 Chinese
公司关于举行2025年度报告网上业绩说明会的公告
Investor Presentation Classification · 1% confidence The document is an announcement of an online performance explanation meeting (‘业绩说明会’) for the 2025 Annual Report. It provides details on the date, format, participation methods, and speakers, but does not itself contain full financial results or slides. Such investor‐focused events and presentations, even when announced rather than included, are classified as Investor Presentations (IP).
2026-04-16 Chinese
公司2025年度内部控制评价报告
Audit Report / Information Classification · 1% confidence The document is titled “2025年度内部控制评价报告” (2025 Internal Control Evaluation Report) and contains in-depth evaluation of internal control effectiveness, descriptions of the control framework, defect definitions, conclusions on no material deficiencies, and governance responsibilities. It is not an annual report or earnings release, nor just an announcement; it is a standalone evaluation/audit-related report concerning internal control effectiveness. This matches the definition of an audit report/information (AR).
2026-04-16 Chinese
关于“质量回报双提升”行动方案的进展公告
Regulatory Filings Classification · 1% confidence The document is a strategic “行动方案” (action plan) issued by the company in response to a Shenzhen Stock Exchange initiative, outlining operational, innovation, governance, and investor-return enhancements. It is not an annual or interim financial report, earnings release, management discussion of results, dividend notice, share issuance, or M&A, nor is it a formal presentation or proxy solicitation. It is a general regulatory‐style announcement without fitting any highly specific category, so it falls under the fallback “Regulatory Filings (RNS)” category.
2026-04-16 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.